ECMO during the COVID-19 pandemic: When is it justified?
Crit Care
.
2020 Nov 19;24(1):650.
doi: 10.1186/s13054-020-03386-4.
Authors
Silver Heinsar
1
2
3
,
Giles J Peek
4
,
John F Fraser
5
6
7
Affiliations
1
Critical Care Research Group (CCRG), The Prince Charles Hospital, Chermside, Brisbane, QLD, Australia. s.heinsar@uq.edu.au.
2
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. s.heinsar@uq.edu.au.
3
St Andrews War Memorial Hospital, Brisbane, QLD, Australia. s.heinsar@uq.edu.au.
4
Shand's Congenital Heart Center, University of Florida, Gainesville, FL, USA.
5
Critical Care Research Group (CCRG), The Prince Charles Hospital, Chermside, Brisbane, QLD, Australia.
6
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
7
St Andrews War Memorial Hospital, Brisbane, QLD, Australia.
PMID:
33213485
PMCID:
PMC7676751
DOI:
10.1186/s13054-020-03386-4
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / epidemiology
COVID-19 / therapy*
Extracorporeal Membrane Oxygenation / methods*
Humans
Pandemics*
Patient Selection*
SARS-CoV-2*